Slower Growth Forecast For US Drug Market In 2009

Law360, New York (October 29, 2008, 12:00 AM EDT) -- U.S. pharmaceutical sales are set for meager growth next year, facing a combination of continuing patent expirations, fewer new product launches, and a tough economy, according to a report issued Wednesday.

The U.S. pharmaceutical market, the world's largest, is set to grow between 1 and 2 percent, the slowest growth rate on record, according a study done by IMS Health.

Drug sales have slowed in the U.S. over the past few years, as blockbuster drugs have lost patent protection, and many pharmaceutical companies have yet to...
To view the full article, register now.